Safety and effectiveness of azithromycin in the treatment of respiratory infections in children

Current Medical Research and Opinion

Volumn 28, Issue 1, 2012, Pages 155-162

  Lakoš, Adela Kolumbić ^a   Pangerčić, Ana ^b   Gašparić, Maja ^a   Kukuruzović, Mirjana Matrapazovski ^b   Kovačić, Dražen ^a   Barić, Bruno ^c  

^a PLIVA CROATIA LTD   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Croatia   (Croatia)

Author keywords

Azithromycin; Otitis media; Pharyngitis; Pneumonia

Indexed keywords

AZITHROMYCIN;

ABDOMINAL PAIN; ACUTE OTITIS MEDIA; ADOLESCENT; ARTICLE; CHILD; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFANT; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT SATISFACTION; PHARYNGITIS; PRESCHOOL CHILD; PRESCRIPTION; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; SCORING SYSTEM; TONSILLITIS; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VOMITING;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

EID: 84855933633     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.639355     Document Type: Article

References (39)

1. Wald ER, Dashefky B, Byers C, et al. Frequency and severity of infections in day care. J Pediatr 1988;112:540-6
2. Wald ER, Guerra N, Byers C. Upper respiratory tract infection in young children: duration of and frequency of complications. Pediatrics 1991;87:129-33
3. Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemiology and etiology of childhood pneumonia. Bull WHO 2008;86:408-16 (Pubitemid 351694322)
4. Kabra SK, Lodha R, Pandey RM. Antibiotics for community acquired pneumonia in children. Cochrane Database of Systemic Reviews 2010; Issue 3. Art. No. CD004874. DOI: 10.1002/14651858.CD004874.pub3
5. Tä htinen PA, Laine MK, Huovinen P, et al. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med 2011;364: 116-26
6. Hoberman A, Paradise JL, Rockette HE, et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med 2011;364:105-15
7. Fried VM, Makuc DM, Rooks RN. Ambulatory health care visits by children: principal diagnosis and place of visit. Vital Health Stat 1998;13:1-23
8. Finkelstein JA, Metlay JP, Davis RL, et al. Antimicrobial use in defined populations of infants and young children. Arch Pediatr Adolesc Med 2000;154:395-400 (Pubitemid 30198490)
9. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis 2004;23:824-8 (Pubitemid 40221024)
10. Regoli M, Chiappini E, Bonsignori F, et al. Update on the management of acute pharyngitis in children. Ital J Pediatr 2011;37:10
11. Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics 2010;126: e557-64
12. Dunn CJ, Barradell LB. Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. Drugs 1996;51:483-505
13. Maskell JP Sefton AM, Williams JD. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes. J Antimicrob Chemother 1990;25(Suppl A):19-24 (Pubitemid 20043945)
14. Goldstein FW, Emirian MF, Coutrot A, et al. Bacteriostatic and bactericidal activity of azithromcycin against Haemophilus influenzae. J Antimicrob Chemother 1990;25(Suppl A):25-8 (Pubitemid 20043946)
15. Kitzis MD, Goldstein FW, Miegi M, et al. In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria. J Antimicrob Chemother 1990;25(Suppl A):15-18 (Pubitemid 20043944)
16. Neu HC. Clinical microbiology of azithromycin. Am J Med 1991;91(Suppl 3A): 12-18
17. Jones RN, Sader HS, Moet GJ, et al. Declining antimicrobial susceptibility of Streptococcus pneumoniae in the United States: report from the SENTRY Antimicrobial Surveillance Program (1998-2009). Diagn Microbiol Infect Dis 2010;68:334-6
18. Doern GV, Richter SS, Miller A, et al. Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes? Clin Infect Dis 2005; 41:139-48 (Pubitemid 40962493)
19. Nahata MC, Koranyi DI, Gadgil SD, et al. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. Antimicrob Agents Chemother 1993;37:314-16 (Pubitemid 23046575)
20. Drew RH, Gallis HA. Azithromycin: spectrum of activity, pharmacokinetics and clinical applications. Pharmacotherapy 1993;12:161-73
21. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990;25(Suppl A):73-82 (Pubitemid 20043952)
22. Pukander J, Rautianen M. Penetration of azithromycin into middle ear effusions in the acute and secretory otitis media in children. J Antimicrob Chemother 1996;37(Suppl C):53-61 (Pubitemid 26283380)
23. Pichichero ME. Short course of antibiotic in acute otitis media and sinusitis infections. J Int Med Res 2000;28:25-36A
24. Weippl G. Multicenter comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci. J Antimicrob Chemother 1993;31(Suppl E):95-101 (Pubitemid 23220193)
25. Schaad U, Heynen G. the Swiss tonsillopharyngitis study group. Evaluation of the efficacy, safety and toleration of azithromycin vs. Penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. Pediatr Infect Dis J 1996;15:791-5 (Pubitemid 26304454)
26. Arguedas A, Loaiza C, Herrera M, et al. Comparative trial of 3-day azithromycin versus 10-day amoxycillin/clavulanate potassium in the treatment of children with acute otitis media with effusion. Int J Antimicrob Agents 1996;6:233-8 (Pubitemid 26128350)
27. Aronovitz G. A multicenter, open label trial of azithromycin vs. amoxicillin/clavulanate for the management of acute otitis media in children. Pediatr Infect Dis J 1996;15:S15-19
28. Arrieta A, Arguedas A, Fernandez P, et al. High dose azithromycin versus high dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media. Antimicrob Agents Chemother 2003;47: 3179-86 (Pubitemid 37229576)
29. Cohen R, Reinert P, de la Rocque F, et al. Comparison of two dosages of azithromycin for 3 days versus penicillin V for ten days in acute Group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2002;21:297-303 (Pubitemid 34326867)
30. Panpanich R, Lertrakarnnon P, Laopaiboon M. Azithromycin for acute lower respiratory tract infections. Cochrane Database Syst Rev 2008; 23(1):CD001954
31. Ferwerda A, Moll HA, Hop WCJ, et al. Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections. J Antimicrob Chemother 2001;47:441-6 (Pubitemid 32303410)
32. Lauvau DV, Verbist L. An open, multicentre, comparative study of the efficacy and safety of azithromycin and co-amoxiclav in the treatment of upper and lower respiratory tract infections in children. The Paediatric Azithromycin Study Group. J Int Med Res 1997;25:285-95 (Pubitemid 27472757)
33. Blasi F, Cazzola M, Tarsia P, et al. Azithromycin and lower respiratory tract infections. Expert Opin Pharmacother 2005;6:2335-51 (Pubitemid 41582219)
34. Jackson MA, Burry VF, Olson LC, et al. Breakthrough sepsis in macrolide-resistant pneumococcal infection. Pediatr Infect Dis J 1996;15:1049-51 (Pubitemid 26403806)
35. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995;333:1618-24
36. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002;346:429-37
37. Heiskanen-Kosma T, Korppi M, et al. Chlamydia pneumonia is an important cause in community-acquired pneumonia in school-aged children: serological results of prospective, population based study. Scand J Infect Dis 1999;31:255-9 (Pubitemid 29389232)
38. Wubbel L, Muniz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J 1999;18:98-104 (Pubitemid 29101880)
39. Mulholland S, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumonia in children. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD004875. DOI:10.1002/14651858.CD004875.pub3